Adams GC, Devlin JE, Klontz E, Laing RA, Branda JA. Development of a Combined Clinical and Research-Developed Testing Strategy for Highly Pathogenic Avian Influenza A Virus H5. Open Forum Infect Dis. 2025 Dec 10;13(1):ofaf744
Highly pathogenic avian influenza A (H5) virus continues to spread in animals with ongoing concern for potential human transmission. We describe an adaptable H5 screening approach that integrates clinical laboratory workflows with research-developed assays. This strategy efficiently screened thousands of samples, providing a practical and scalable model for H5 surveillance.
See Also:
Latest articles in those days:
- T cell help is a limiting factor for rare anti-influenza memory B cells to reenter germinal centers and generate potent broadly neutralizing antibodies 20 hours ago
- Wild birds drive the introduction, maintenance, and spread of H5N1 clade 2.3.4.4b high pathogenicity avian influenza viruses in Spain, 2021-2022 20 hours ago
- [preprint]FluNexus: a versatile web platform for antigenic prediction and visualization of influenza A viruses 21 hours ago
- Salpingitis and multiorgan lesions caused by highly pathogenic avian influenza A(H5N1) virus in a cat associated with consumption of recalled raw milk in California 21 hours ago
- Detection of highly pathogenic avian influenza A(H5N1) virus 2.3.4.4b in alpacas 21 hours ago
[Go Top] [Close Window]
